Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Renal Sympathetic Denervation Attenuates Congestive Heart Failure in Angiotensin II-Dependent Hypertension: Studies with Ren-2 Transgenic Hypertensive Rats with Aortocaval Fistula

Z. Honetschlagerová, O. Gawrys, Š. Jíchová, P. Škaroupková, S. Kikerlová, Z. Vaňourková, Z. Husková, V. Melenovský, E. Kompanowska-Jezierska, J. Sadowski, F. Kolář, J. Novotný, L. Hejnová, P. Kujal, L. Červenka

. 2021 ; 46 (1) : 95-113. [pub] 20210202

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21019573

OBJECTIVE: We examined if renal denervation (RDN) attenuates the progression of aortocaval fistula (ACF)-induced heart failure or improves renal hemodynamics in Ren-2 transgenic rats (TGR), a model of angiotensin II (ANG II)-dependent hypertension. METHODS: Bilateral RDN was performed 1 week after creation of ACF. The animals studied were ACF TGR and sham-operated controls, and both groups were subjected to RDN or sham denervation. In separate groups, renal artery blood flow (RBF) responses were determined to intrarenal ANG II (2 and 8 ng), norepinephrine (NE) (20 and 40 ng) and acetylcholine (Ach) (10 and 40 ng) 3 weeks after ACF creation. RESULTS: In nondenervated ACF TGR, the final survival rate was 10 versus 50% in RDN rats. RBF was significantly lower in ACF TGR than in sham-operated TGR (6.2 ± 0.3 vs. 9.7 ± 0.5 mL min-1 g-1, p < 0.05), the levels unaffected by RDN. Both doses of ANG II decreased RBF more in ACF TGR than in sham-operated TGR (-19 ± 3 vs. -9 ± 2% and -47 ± 3 vs. -22 ± 2%, p < 0.05 in both cases). RDN did not alter RBF responses to the lower dose, but increased it to the higher dose of ANG II in sham-operated as well as in ACF TGR. NE comparably decreased RBF in ACF TGR and sham-operated TGR, and RDN increased RBF responsiveness. Intrarenal Ach increased RBF significantly more in ACF TGR than in sham-operated TGR (29 ± 3 vs. 17 ± 3%, p < 0.05), the changes unaffected by RDN. ACF creation induced marked bilateral cardiac hypertrophy and lung congestion, both attenuated by RDN. In sham-operated but not in ACF TGR, RDN significantly decreased mean arterial pressure. CONCLUSION: The results show that RDN significantly improved survival rate in ACF TGR; however, this beneficial effect was not associated with improvement of reduced RBF or with attenuation of exaggerated renal vascular responsiveness to ANG II.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019573
003      
CZ-PrNML
005      
20220530151114.0
007      
ta
008      
210728s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1159/000513071 $2 doi
035    __
$a (PubMed)33530085
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Honetschlagerová, Zuzana $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czechia, zubu@medicon.cz
245    10
$a Renal Sympathetic Denervation Attenuates Congestive Heart Failure in Angiotensin II-Dependent Hypertension: Studies with Ren-2 Transgenic Hypertensive Rats with Aortocaval Fistula / $c Z. Honetschlagerová, O. Gawrys, Š. Jíchová, P. Škaroupková, S. Kikerlová, Z. Vaňourková, Z. Husková, V. Melenovský, E. Kompanowska-Jezierska, J. Sadowski, F. Kolář, J. Novotný, L. Hejnová, P. Kujal, L. Červenka
520    9_
$a OBJECTIVE: We examined if renal denervation (RDN) attenuates the progression of aortocaval fistula (ACF)-induced heart failure or improves renal hemodynamics in Ren-2 transgenic rats (TGR), a model of angiotensin II (ANG II)-dependent hypertension. METHODS: Bilateral RDN was performed 1 week after creation of ACF. The animals studied were ACF TGR and sham-operated controls, and both groups were subjected to RDN or sham denervation. In separate groups, renal artery blood flow (RBF) responses were determined to intrarenal ANG II (2 and 8 ng), norepinephrine (NE) (20 and 40 ng) and acetylcholine (Ach) (10 and 40 ng) 3 weeks after ACF creation. RESULTS: In nondenervated ACF TGR, the final survival rate was 10 versus 50% in RDN rats. RBF was significantly lower in ACF TGR than in sham-operated TGR (6.2 ± 0.3 vs. 9.7 ± 0.5 mL min-1 g-1, p < 0.05), the levels unaffected by RDN. Both doses of ANG II decreased RBF more in ACF TGR than in sham-operated TGR (-19 ± 3 vs. -9 ± 2% and -47 ± 3 vs. -22 ± 2%, p < 0.05 in both cases). RDN did not alter RBF responses to the lower dose, but increased it to the higher dose of ANG II in sham-operated as well as in ACF TGR. NE comparably decreased RBF in ACF TGR and sham-operated TGR, and RDN increased RBF responsiveness. Intrarenal Ach increased RBF significantly more in ACF TGR than in sham-operated TGR (29 ± 3 vs. 17 ± 3%, p < 0.05), the changes unaffected by RDN. ACF creation induced marked bilateral cardiac hypertrophy and lung congestion, both attenuated by RDN. In sham-operated but not in ACF TGR, RDN significantly decreased mean arterial pressure. CONCLUSION: The results show that RDN significantly improved survival rate in ACF TGR; however, this beneficial effect was not associated with improvement of reduced RBF or with attenuation of exaggerated renal vascular responsiveness to ANG II.
650    _2
$a angiotensin II $x metabolismus $7 D000804
650    _2
$a zvířata $7 D000818
650    _2
$a arteriovenózní píštěl $x komplikace $7 D001164
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a srdeční selhání $x komplikace $x genetika $x metabolismus $x terapie $7 D006333
650    _2
$a hypertenze $x komplikace $x genetika $x metabolismus $7 D006973
650    _2
$a ledviny $x inervace $x chirurgie $7 D007668
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Sprague-Dawley $7 D017207
650    _2
$a potkani transgenní $7 D055647
650    _2
$a renin $x genetika $7 D012083
650    12
$a sympatektomie $7 D013562
655    _2
$a časopisecké články $7 D016428
700    1_
$a Gawrys, Olga $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czechia $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czechia
700    1_
$a Jíchová, Šárka $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czechia
700    1_
$a Škaroupková, Petra $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czechia
700    1_
$a Kikerlová, Soňa $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czechia
700    1_
$a Vaňourková, Zdeňka $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czechia
700    1_
$a Husková, Zuzana $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czechia
700    1_
$a Melenovský, Vojtěch $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czechia
700    1_
$a Kompanowska-Jezierska, Elżbieta, $u Department of Renal and Body Fluid Physiology, Mossakowski Medical Research Centre, Polish Academy of Science, Warsaw, Poland $d 1959- $7 xx0273376
700    1_
$a Sadowski, Janusz $u Department of Renal and Body Fluid Physiology, Mossakowski Medical Research Centre, Polish Academy of Science, Warsaw, Poland
700    1_
$a Kolář, František $u Department of Developmental Cardiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia
700    1_
$a Novotný, Jiří $u Department of Physiology, Faculty of Science, Charles University in Prague, Prague, Czechia
700    1_
$a Hejnová, Lucie $u Department of Physiology, Faculty of Science, Charles University in Prague, Prague, Czechia
700    1_
$a Kujal, Petr $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czechia $u Department of Pathology, 3rd Faculty of Medicine, Charles University, Prague, Czechia
700    1_
$a Červenka, Luděk $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czechia
773    0_
$w MED00003064 $t Kidney & blood pressure research $x 1423-0143 $g Roč. 46, č. 1 (2021), s. 95-113
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33530085 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20220530151112 $b ABA008
999    __
$a ok $b bmc $g 1690414 $s 1140019
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 46 $c 1 $d 95-113 $e 20210202 $i 1423-0143 $m Kidney & blood pressure research $n Kidney Blood Press Res $x MED00003064
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Možnosti archivace